- funded by IMI-JU
- 01 March 2011 - 31 August 2016
- 11 EFPIA members
- 10 Academia and 5 SME's
- Total cost € 23,032,609
This Pharma lead DDMoRe course in Cardiac Safety evaluation is one in a series of comprehensive face-to-face courses introducing the principles of model-informed drug discovery and development, covering a range of therapeutic areas, via the newly-developed DDMoRe interoperability framework.
The Department of Quantitative Clinical Pharmacology, AstraZeneca R&D Gothenburg, Sweden together with the Institute of Pharmacy, Freie Universitaet Berlin, Germany are happy to invite you to the following face-to-face course:
“Model-informed Drug Development in Cardiac Safety”
Dates: 18-22 January 2016
Venue: AstraZeneca R&D Gothenburg site, Pepparedsleden 1, Mölndal, Sweden
Intended for: All people interested and working in the quantitative life sciences field, course materials will be focused towards PhD student and Postdoc fellows.
Topics: Model-informed drug discovery and development to evaluate cardiac safety risks and with an introduction to the DDMoRe framework (new modelling & simulation language, model repository, interoperability platform)
Program: Lectures, hands-on sessions, group work, workshop, and particpant presentations
Course directors: Charlotte Kloft, Zinnia Parra-Guillen, Amy Cheung, Corina Dota
• Are you willing to actively participate in the course and give constructive feedback to further improve the DDMoRe developments?
• Are you able to bring along a laptop that fulfills the minimum IT environment requirements specified here?
If your answer is “yes” to the above, then download the application form found at the bottom of this page; further information on ‘prerequisites for application’ can be found on the application form.
Fee: Free of charge (transport, accommodation and food not included)
Maximum number of participants: 20(If needed, selection will be based on the registration information, with priority to PhD students/post-docs and participants from different institutions).
Application deadline: 30 December 2015
For more information:
On DDMoRe and the ‘education & training activities: read here
About DDMoRe: http://www.ddmore.eu
We warmly invite you to join us for this public Pharma lead DDMoRe course:
Please download and save the application form found below, before you fill-in and submit to:
email@example.com. Please mention in the subject Cardiac Safety Application